UNITY Biotechnology logo

UNITY Biotechnology

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.

Industries

Employees

11-50

Links


Org chart

Collapse

Board & advisors


Teams


Offices